Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models
Jinwei Hu, Julia Y. Ljubimova, Satoshi Inoue et al. · 2010
Read Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models by Jinwei Hu, Julia Y. Ljubimova, Satoshi Inoue et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010108.txt.
Description
The authors were Jinwei Hu, Julia Ljubimova, Satoshi Inoue, and others. Their 2010 PLOS ONE study tackled drug delivery to brain tumors in mice. Most cancer drugs reach body tumors well enough. Brain tumors hide behind a blood-brain tumor barrier that keeps many drugs out, sharply limiting treatment there.
The team tested type 5 phosphodiesterase inhibitors, a known drug class, as helpers. In mouse models of metastatic brain tumors, those drugs raised transport of Herceptin, an antibody drug. They also improved how well that treatment worked, offering a route around the barrier.
Catalog record
| CREATOR | Jinwei Hu, Julia Y. Ljubimova, Satoshi Inoue et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010108